1251.2000 3.00 (0.24%)
NSE May 30, 2025 15:31 PM
Volume: 3.2M
 

1251.20
0.24%
Emkay
Adjusted for the milestone payment received from Journey Medical Corp, 3QFY25 EBITDA for Dr Reddy’s was below street/our estimates. The PAT miss was higher on account of lower other income.
Dr. Reddy's Laboratories Ltd. is trading below its 200 day SMA of 1256.9
More from Dr. Reddy's Laboratories Ltd.
Recommended